FAT1 and neoplasm: In vivo gene depletion of mutant FAT1 with LNP‐sgFAT1 suppresses tumor growth and restores CPI‐613 sensitivity, revealing a targetable metabolic bypass with therapeutic potential in FAT1‐mutant cancer.